Johnson & Johnson (JNJ) Tops Q3 EPS by 3c, Revenues Beat; Maintains Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. GOOGL
6. RTX
7. COF
8. SMCI
9. TSLA
10. BRZE

Go back to Johnson & Johnson (JNJ) Tops Q3 EPS by 3c, Revenues Beat; Maintains Outlook

Johnson & Johnson Reports Q3 2022 Results

October 18, 2022 6:25 AM EDT

Reported sales growth of 1.9% to $23.8 Billion with operational growth of 8.1%* and adjusted operational growth of 8.2%* Earnings per share (EPS) of $1.68 increasing 22.6% and adjusted EPS of $2.55 decreasing by 1.9%* Company is maintaining 2022 full-year guidance midpoints for adjusted operational sales and reported adjusted EPS; increasing adjusted operational EPS performance offsetting continued unfavorable currency impacts

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2022. Our third quarter performance demonstrates our continued strength and resilience across all three of our businesses, said Joaquin... More